Heart Disease and Erectile Dysfunction
13%
off

Heart Disease and Erectile Dysfunction

Edited by 

Free delivery worldwide

Available. Dispatched from the UK in 3 business days
When will my order arrive?

Description

Senior physicians, cardiologists, urologists, psychologists, and pharmacologists critically review the relation between heart disease and erectile dysfunction (ED) and explain for the practicing physician the effective new treatment options available for the cardiac patient with ED. The authors detail in concise language the latest thinking about the risk of sexually induced cardiac events, the efficacy and risks to cardiac patients of drugs used to treat sexual dysfunction, and the expert guidelines developed by prominent organizations on the optimal approach to sexual dysfunction in the cardiac patient. They also discuss the physiology of ED and the currently available therapies (sildenafil, tadalafil, and vardenafil) may interact with the cardiac system, and the potential application of newer agents like phosphodiesterase-5 inhibitors to cardiovascular disease.
show more

Product details

  • Hardback | 300 pages
  • 152.4 x 231.1 x 27.9mm | 635.04g
  • Totowa, NJ, United States
  • English
  • 2004 ed.
  • 40 Illustrations, black and white; X, 300 p. 40 illus.
  • 1588292169
  • 9781588292162

Back cover copy

It is now generally appreciated that heart disease and its attendant risk factors are a leading cause of erectile dysfunction (ED) and that ED is often an early warning sign of vascular disease. In Heart Disease and Erectile Dysfunction, senior physicians, cardiologists, urologists, psychologists, and pharmacologists critically review the relationship between heart disease and erectile dysfunction and explain for the practicing physician the effective new treatment options available for the cardiac patient with ED. The authors detail in concise language the latest thinking about the risk of sexually induced cardiac events, the efficacy and risks to cardiac patients of drugs used to treat sexual dysfunction, and the expert guidelines developed by prominent organizations on the optimal approach to sexual dysfunction in the cardiac patient. They also discuss the physiology of ED and how the currently available therapies (sildenafil, tadalafil, and vardenafil) may interact with the cardiac system, and the potential application of newer phosphodiesterase-5 inhibitors to cardiovascular disease.
Comprehensive and pathbreaking, Heart Disease and Erectile Dysfunction not only clearly delineates for practicing physicians all aspects of the interaction between the vascular system and erectile dysfunction, but also establishes a sound medical basis for the management of cardiac patients suffering erectile disorders.
show more

Table of contents

Physiology of Erection and Causes of Erectile Dysfunction
Aristotelis G. Anastasiadis, Dmitry Droggin, Martin Burchardt, and Ridwan Shabsigh

Erectile Dysfunction: The Scope of the Problem
Culley C. Carson

Erectile Dysfunction and Cardiovascular Risk Factors
Robert A. Kloner

Psychologic Aspects of Erectile Dysfunction in Heart Patients
Raymond C. Rosen

Management of Erectile Dysfunction: An Overview
Harin Padma-Nathan

Sildenafil Citrate and the Nitric Oxide/Cyclic Guanosine Monophosphate Signaling Pathway
Ian H. Osterloh and Stephen C. Phillips

Phosphodiesterase-5 Inhibition: Importance to the Cardiovascular System
Jackie D. Corbin, Stephen R. Rannels, and Sharron H. Francis

The Hemodynamics of Phosphodiesterase-PDE5 Inhibitors
Graham Jackson

Cardiovascular Safety of Phosphodiesterase-5 Inhibitors
Robert A. Kloner

Effect of Phosphodiesterase-5 Inhibition on Coronary Blood Flow in Experimental Animals
YingJie Chen, Jay H. Traverse, and Robert J. Bache

Safety and Hemodynamic Effects of Sildenafil in Patients With Coronary Artery Disease
Sameer Rohatgi and Howard C. Herrmann

Cardiovascular Effects of Nonphosphodiesterase-5 Inhibitor Erectile Dysfunction Therapies
Harin Padma-Nathan

Potential Cardiac Applications of Phosphodiesterase Type-5 Inhibition
Michael Sweeney and Richard L. Siegel

The Physiologic Cost of Sexual Activity
Robert F. DeBusk

Sexual Activity As a Trigger of Myocardial Infarction/Ischemia: Implications for Treating Erectile Dysfunction
Robert A. Kloner

Sex After Cardiac Events and Procedures: Counseling From the Cardiovascular Specialist's Perspective
Herman A. Taylor, Jr.

American College of Cardiology/American Heart Association Guidelines on the Use of Sildenafil in Patients With Cardiovascular Disease
Adolph M. Hutter, Jr.

Risk of Heart Attack After Sexual Activity: The Princeton Guidelines and Their Rationale
Robert F. DeBusk

Index
show more

Review quote

"This is the first book of its kind. Dr. Cloner and colleagues deserve credit for bringing this important topic to the forefront." - Doody's Health Sciences Book Review Journal
show more